| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/01/2004 | CA2498325A1 Prophylactic and therapeutic hiv aptamers |
| 04/01/2004 | CA2498320A1 Anthraquinone quencher dyes, their methods of preparation and use |
| 04/01/2004 | CA2498214A1 Method for the amplification of genetic information |
| 04/01/2004 | CA2498164A1 Functional correction of the -786c/t- variance of the human enos-gene |
| 04/01/2004 | CA2497937A1 Nuclear factor of activated t cells receptor |
| 04/01/2004 | CA2497934A1 Tryptophan hydroxylase assay |
| 04/01/2004 | CA2497635A1 Transgenic expression cassettes for expressing nucleic acids in non-reproductive flower tissues of plants |
| 04/01/2004 | CA2497560A1 Luminescence-based methods and probes for measuring cytochrome p450 activity |
| 04/01/2004 | CA2497555A1 Detection of biological molecules by differential partitioning of enzyme substrates and products |
| 04/01/2004 | CA2497434A1 Inducible focal adhesion kinase cell assay |
| 04/01/2004 | CA2486280A1 Identification of a phage associated lytic enzyme to rapidly and specifically detect and kill bacillus anthracis |
| 04/01/2004 | CA2474680A1 Method for analyzing organelle-localized protein and material for analysis |
| 03/31/2004 | EP1404150A1 Diaphragm structure of light sound converter |
| 03/31/2004 | EP1403643A1 Lawsonia intracellularis cultivation, anti-lawsonia intracelluaris vaccines and diagnostic agents |
| 03/31/2004 | EP1403641A1 Method of calculating association and dissociation constants using a polymer chip for identifying ionic polymers |
| 03/31/2004 | EP1403639A1 Antibody tools for the diagnostic use in the medical therapy with inhibitors of histone deacetylases |
| 03/31/2004 | EP1403638A1 Molecular methods for diagnosing interstitial lung diseases |
| 03/31/2004 | EP1403386A1 Detection of Epstein-Barr virus |
| 03/31/2004 | EP1403385A1 Method for assaying replication of HBV and testing susceptibility to drugs |
| 03/31/2004 | EP1403384A1 Method for detecting and typing of cutaneous HPV and primers and probes for use therein |
| 03/31/2004 | EP1403382A2 Improved fluorescent resonance energy transfer probes |
| 03/31/2004 | EP1403381A1 Improved method for detecting and identifying microorganism causative of infection |
| 03/31/2004 | EP1403380A1 Human obesity susceptibility gene and uses thereof |
| 03/31/2004 | EP1403379A1 Enhanced coamplification of nucleic acids |
| 03/31/2004 | EP1403378A2 Medium for detecting target microbes in a sample |
| 03/31/2004 | EP1403372A2 Composition and methods for the treatment and diagnosis of cardiovascular disease |
| 03/31/2004 | EP1403370A1 Polynucleotide probe and primer for detecting beer-clouding lactic acid bacteria and method of detecting beer-clouding lactic acid bacteria |
| 03/31/2004 | EP1403369A1 Method of evaluating the function of phagocyte and utilization thereof |
| 03/31/2004 | EP1403368A1 Testicular carnitine transporter and its gene |
| 03/31/2004 | EP1403367A1 Method of testing drug for treating or preventing diseases such as hyperlipemia |
| 03/31/2004 | EP1403366A1 Genes with es cell-specific expression |
| 03/31/2004 | EP1403285A1 Fibroblast growth factor receptors |
| 03/31/2004 | EP1402450A2 System and method for integrated analysis of data for characterizing carbohydrate polymers |
| 03/31/2004 | EP1402449A2 Method, system, apparatus and device for discovering and preparing chemical compounds |
| 03/31/2004 | EP1402270A1 Identification of modulators of neurotransmitter activity of xanthurenic acid |
| 03/31/2004 | EP1402267A1 Chp for use as marker for sepsis-type inflammatory diseases |
| 03/31/2004 | EP1402264A1 Assay for beta cell toxic macrolides |
| 03/31/2004 | EP1402262A2 MAP3Ks AS MODIFIER OF THE p53 PATHWAY AND METHODS OF USE |
| 03/31/2004 | EP1402261A1 Colon cancer antigen panel |
| 03/31/2004 | EP1402260A2 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders |
| 03/31/2004 | EP1402257A1 Proteins in diabetes proteome analysis |
| 03/31/2004 | EP1402256A2 P-cadherin as a target for anti-cancer therapy |
| 03/31/2004 | EP1402254A1 Method and apparatus for high-speed approximate sub-string searches |
| 03/31/2004 | EP1402245A1 Methods and apparatus for characterization of single polymers |
| 03/31/2004 | EP1402076A2 Compositions and methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays |
| 03/31/2004 | EP1402075A1 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses |
| 03/31/2004 | EP1402074A2 Methods and compositions using genetic package display |
| 03/31/2004 | EP1402073A1 Methods and compositions for assessment of pulmonary function and disorders |
| 03/31/2004 | EP1402072A1 Accurate and efficient quantification of dna sensitivity by real-time pcr |
| 03/31/2004 | EP1402071A2 Methods and products for analyzing nucleic acids based on methylation status |
| 03/31/2004 | EP1402070A2 Methods for the diagnosis of cancer based on the obcam and ntm genes |
| 03/31/2004 | EP1402069A1 Methods and products for analyzing nucleic acids using nick translation |
| 03/31/2004 | EP1402068A2 Evaluation of ultraviolet radiation damage to skin using new genemarkers, methods and compositions related thereto |
| 03/31/2004 | EP1402067A2 HS2STs AS MODIFIERS OF THE P53 PATHWAY AND METHODS OF USE |
| 03/31/2004 | EP1402065A2 Method for detecting transcription factor-protein interactions |
| 03/31/2004 | EP1402064A2 Protein arrays and methods and systems for producing the same |
| 03/31/2004 | EP1402062A1 Bioinformatics based system for assessing a condition of a performance animal by analysing nucleic acid expression |
| 03/31/2004 | EP1402061A2 Chemical compounds for identification of slc10a2 gene polymorphisms |
| 03/31/2004 | EP1402060A2 Use of semaphorin 3a for diagnosing and treating cancer, especially prostate cancer |
| 03/31/2004 | EP1402059A2 Diagnosis of diseases associated with angiogenesis by determining the methylation of genes associated with angiogenesis |
| 03/31/2004 | EP1402058A2 Dgks as modifiers of the p53 pathway and methods of use |
| 03/31/2004 | EP1402057A2 Method for detecting mutagenic substances |
| 03/31/2004 | EP1402055A1 Method for producing a layer of functional molecules |
| 03/31/2004 | EP1402054A1 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 03/31/2004 | EP1402053A2 CHDs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 03/31/2004 | EP1402051A2 Lces as modifiers of the p53 pathway and methods of use |
| 03/31/2004 | EP1402048A2 Methods of 6-o-sulfating polysaccharides and 6-o-sulfated polysaccharide preparations |
| 03/31/2004 | EP1402042A2 Abiotic stress responsive polynucleotides and polypeptides |
| 03/31/2004 | EP1402040A2 A novel intein and uses thereof |
| 03/31/2004 | EP1402038A2 Identification and characterization of plant genes |
| 03/31/2004 | EP1402037A1 Plant genes involved in defense against pathogens |
| 03/31/2004 | EP1402031A2 Atopy |
| 03/31/2004 | EP1402024A2 Templated molecules and methods for using such molecules |
| 03/31/2004 | EP1402018A1 Unigene unidirectional antisense library |
| 03/31/2004 | EP1402017A1 Random gene unidirectional antisense library |
| 03/31/2004 | EP1402013A2 Homoaconitase as a target for fungicides |
| 03/31/2004 | EP1402009A1 Novel mixed lineage kinase (7) (mlk7) polypeptide, polynucleotides encoding the same, and methods of use thereof |
| 03/31/2004 | EP1402001A2 Anti-microbial peptides and compositions |
| 03/31/2004 | EP1402000A2 Structural and cytoskeleton-associated proteins |
| 03/31/2004 | EP1401999A2 B7 related protein-2 molecules and uses thereof |
| 03/31/2004 | EP1401996A2 Hybridization normalization methods |
| 03/31/2004 | EP1401962A1 Method for increasing hydrophilicity of fluorescent label compounds |
| 03/31/2004 | EP1401867A2 Mycobacterial antigens expressed under low oxygen tension |
| 03/31/2004 | EP1401866A2 Comparative mycobacterial genomics as a tool for identifying targets for the diagnosis, prophylaxis or treatment of mycobacterioses |
| 03/31/2004 | EP1401861A2 Cads as modifiers of the p53 pathway and methods of use |
| 03/31/2004 | EP1401859A2 Chimeric flavivirus vectors |
| 03/31/2004 | EP1401855A2 Novel fibroblast growth factor and nucleic acids encoding same |
| 03/31/2004 | EP1401854A2 Methods of detecting, diagnosing and treating cancer and identifying neoplastic progression |
| 03/31/2004 | EP1401853A1 Modulators of pharmacological agents |
| 03/31/2004 | EP1401849A1 Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes |
| 03/31/2004 | EP1401804A1 Catalase inactivating compounds and their use |
| 03/31/2004 | EP1401490A1 Tsg101 as inhibitor of hiv production |
| 03/31/2004 | EP1401475A2 Prmts as modifiers of the p53 pathway and methods of use |
| 03/31/2004 | EP1401472A2 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 03/31/2004 | EP1401470A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
| 03/31/2004 | EP1401469A2 Therapeutic use and identification of modulators of a hedgehog signalling pathway or one of its target pathways |
| 03/31/2004 | EP1401429A2 Use of potent, selective and non toxic c-kit inhibitors for treating mastocytosis |
| 03/31/2004 | EP1401420A2 Perturbed membrane-binding compounds |
| 03/31/2004 | EP1401410A2 Immunomodulation and effect on cell processes relating to serotonin family receptors |
| 03/31/2004 | EP1401401A2 Method for high through put screening using a small scale mill or microfluidics |